Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation von Newberry, Kate J., Patel, Keyur, Masarova, Lucia, Luthra, Rajyalakshmi, Manshouri, Taghi, Jabbour, Elias, Bose, Prithviraj, Daver, Naval, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan

Volltext

Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis von Verstovsek, Srdan, Manshouri, Taghi, Pilling, Darrell, Bueso-Ramos, Carlos E, Newberry, Kate J, Prijic, Sanja, Knez, Liza, Bozinovic, Ksenija, Harris, David M, Spaeth, Erika L, Post, Sean M, Multani, Asha S, Rampal, Raajit K, Ahn, Jihae, Levine, Ross L, Creighton, Chad J, Kantarjian, Hagop M, Estrov, Zeev

Volltext

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial von Wang, Michael, Dr, Fayad, Luis, MD, Wagner-Bartak, Nicolaus, MD, Zhang, Liang, MD, Hagemeister, Fredrick, Prof, Neelapu, Sattva S, MD, Samaniego, Felipe, MD, McLaughlin, Peter, MD, Fanale, Michelle, MD, Younes, Anas, Prof, Cabanillas, Fernando, MD, Fowler, Nathan, MD, Newberry, Kate J, PhD, Sun, Luhong, PhD, Young, Ken H, MD, Champlin, Richard, Prof, Kwak, Larry, Prof, Feng, Lei, MS, Badillo, Maria, BS, Bejarano, Maria, MD, Hartig, Kimberly, Chen, Wendy, PA, Chen, Yiming, MD, Byrne, Catriona, RN, Bell, Neda, BS, Zeldis, Jerome, MD, Romaguera, Jorge, Prof

Volltext

Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial von Masarova, Lucia, MD, Patel, Keyur P, MD, Newberry, Kate J, PhD, Cortes, Jorge, Prof, Borthakur, Gautam, MD, Konopleva, Marina, Prof, Estrov, Zeev, Prof, Kantarjian, Hagop, Prof, Verstovsek, Srdan, Prof

Volltext

Structural Mechanism of Organic Hydroperoxide Induction of the Transcription Regulator OhrR von Newberry, Kate J., Fuangthong, Mayuree, Panmanee, Warunya, Mongkolsuk, Skorn, Brennan, Richard G.

Volltext

Promoter recognition by a complex of Spx and the C-terminal domain of the RNA polymerase alpha subunit von Nakano, Michiko M, Lin, Ann, Zuber, Cole S, Newberry, Kate J, Brennan, Richard G, Zuber, Peter

Volltext

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV) von Masarova, Lucia, Yin, C Cameron, Cortes, Jorge E, Konopleva, Marina, Borthakur, Gautam, Newberry, Kate J, Kantarjian, Hagop M, Bueso-Ramos, Carlos E, Verstovsek, Srdan

Volltext

The Structural Mechanism for Transcription Activation by MerR Family Member Multidrug Transporter Activation, N Terminus von Newberry, Kate J, Brennan, Richard G

Volltext

Crystal Structure of the Bacillus subtilis Anti-Alpha, Global Transcriptional Regulator, Spx, in Complex with the α C-Terminal Domain of RNA Polymerase von Kate J. Newberry, Nakano, Shunji, Zuber, Peter, Brennan, Richard G., Losick, Richard M.

Volltext

Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcome von Masarova, Lucia, Newberry, Kate J, Pierce, Sherry A, Estrov, Zeev, Cortes, Jorge E, Kantarjian, Hagop M, Verstovsek, Srdan

Volltext

Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib von Patel, Keyur P., Newberry, Kate J., Luthra, Rajyalakshmi, Jabbour, Elias, Pierce, Sherry, Cortes, Jorge, Singh, Rajesh, Mehrotra, Meenakshi, Routbort, Mark J., Luthra, Madan, Manshouri, Taghi, Santos, Fabio P., Kantarjian, Hagop, Verstovsek, Srdan

Volltext

Conformational Plasticity of the Coiled-Coil Domain of BmrR Is Required for bmr Operator Binding: The Structure of Unliganded BmrR von Kumaraswami, Muthiah, Newberry, Kate J., Brennan, Richard G.

Volltext

Pentraxin‐3 plasma levels correlate with tumour burden and overall survival in patients with primary myelofibrosis von Veletic, Ivo, Manshouri, Taghi, Newberry, Kate J., Garnett, Jeannine, Verstovsek, Srdan, Estrov, Zeev

Volltext

Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis von Masarova, Lucia, Bose, Prithviraj, Daver, Naval, Pemmaraju, Naveen, Newberry, Kate J, Manshouri, Taghi, Cortes, Jorge, Kantarjian, Hagop M, Verstovsek, Srdan

Volltext

Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment? von Falchi, Lorenzo, Bose, Prithviraj, Newberry, Kate J., Verstovsek, Srdan

Volltext

Structures of BmrR-Drug Complexes Reveal a Rigid Multidrug Binding Pocket and Transcription Activation through Tyrosine Expulsion von Newberry, Kate J., Huffman, Joy L., Miller, Marshall C., Vazquez-Laslop, Nora, Neyfakh, Alex A., Brennan, Richard G.

Volltext

Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid... von Badar, Talha, Kantarjian, Hagop M, Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Cortes, Jorge E, Pemmaraju, Naveen, Pierce, Sherry R, Newberry, Kate J, Daver, Naval, Verstovsek, Srdan

Volltext

Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis von Masarova, Lucia, Wang, Wei, Newberry, Kate J., Kantarjian, Hagop, Verstovsek, Srdan

Volltext

Therapy-related myelofibrosis does not appear to exist von Masarova, Lucia, Todisco, Gabriele, Manshouri, Taghi, Newberry, Kate J., Cortes, Jorge E., Kantarjian, Hagop M., Estrov, Zeev, Verstovsek, Srdan

Volltext

New Therapeutic Approaches in Polycythemia Vera von Falchi, Lorenzo, Newberry, Kate J, Verstovsek, Srdan

Volltext